Cargando…
The maximum contraceptive prevalence ‘demand curve’: guiding discussions on programmatic investments
Most frameworks for family planning include both access and demand interventions. Understanding how these two are linked and when each should be prioritized is difficult. The maximum contraceptive prevalence ‘demand curve’ was created based on a relationship between the modern contraceptive prevalen...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771155/ https://www.ncbi.nlm.nih.gov/pubmed/29355228 http://dx.doi.org/10.12688/gatesopenres.12780.1 |
_version_ | 1783293211877310464 |
---|---|
author | Weinberger, Michelle Sonneveldt, Emily Stover, John |
author_facet | Weinberger, Michelle Sonneveldt, Emily Stover, John |
author_sort | Weinberger, Michelle |
collection | PubMed |
description | Most frameworks for family planning include both access and demand interventions. Understanding how these two are linked and when each should be prioritized is difficult. The maximum contraceptive prevalence ‘demand curve’ was created based on a relationship between the modern contraceptive prevalence rate (mCPR) and mean ideal number of children to allow for a quantitative assessment of the balance between access and demand interventions. The curve represents the maximum mCPR that is likely to be seen given fertility intentions and related norms and constructs that influence contraceptive use. The gap between a country’s mCPR and this maximum is referred to as the ‘potential use gap.’ This concept can be used by countries to prioritize access investments where the gap is large, and discuss implications for future contraceptive use where the gap is small. It is also used within the FP Goals model to ensure mCPR growth from access interventions does not exceed available demand. |
format | Online Article Text |
id | pubmed-5771155 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-57711552018-01-19 The maximum contraceptive prevalence ‘demand curve’: guiding discussions on programmatic investments Weinberger, Michelle Sonneveldt, Emily Stover, John Gates Open Res Method Article Most frameworks for family planning include both access and demand interventions. Understanding how these two are linked and when each should be prioritized is difficult. The maximum contraceptive prevalence ‘demand curve’ was created based on a relationship between the modern contraceptive prevalence rate (mCPR) and mean ideal number of children to allow for a quantitative assessment of the balance between access and demand interventions. The curve represents the maximum mCPR that is likely to be seen given fertility intentions and related norms and constructs that influence contraceptive use. The gap between a country’s mCPR and this maximum is referred to as the ‘potential use gap.’ This concept can be used by countries to prioritize access investments where the gap is large, and discuss implications for future contraceptive use where the gap is small. It is also used within the FP Goals model to ensure mCPR growth from access interventions does not exceed available demand. F1000 Research Limited 2017-12-22 /pmc/articles/PMC5771155/ /pubmed/29355228 http://dx.doi.org/10.12688/gatesopenres.12780.1 Text en Copyright: © 2017 Weinberger M et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Method Article Weinberger, Michelle Sonneveldt, Emily Stover, John The maximum contraceptive prevalence ‘demand curve’: guiding discussions on programmatic investments |
title | The maximum contraceptive prevalence ‘demand curve’: guiding discussions on programmatic investments |
title_full | The maximum contraceptive prevalence ‘demand curve’: guiding discussions on programmatic investments |
title_fullStr | The maximum contraceptive prevalence ‘demand curve’: guiding discussions on programmatic investments |
title_full_unstemmed | The maximum contraceptive prevalence ‘demand curve’: guiding discussions on programmatic investments |
title_short | The maximum contraceptive prevalence ‘demand curve’: guiding discussions on programmatic investments |
title_sort | maximum contraceptive prevalence ‘demand curve’: guiding discussions on programmatic investments |
topic | Method Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771155/ https://www.ncbi.nlm.nih.gov/pubmed/29355228 http://dx.doi.org/10.12688/gatesopenres.12780.1 |
work_keys_str_mv | AT weinbergermichelle themaximumcontraceptiveprevalencedemandcurveguidingdiscussionsonprogrammaticinvestments AT sonneveldtemily themaximumcontraceptiveprevalencedemandcurveguidingdiscussionsonprogrammaticinvestments AT stoverjohn themaximumcontraceptiveprevalencedemandcurveguidingdiscussionsonprogrammaticinvestments AT weinbergermichelle maximumcontraceptiveprevalencedemandcurveguidingdiscussionsonprogrammaticinvestments AT sonneveldtemily maximumcontraceptiveprevalencedemandcurveguidingdiscussionsonprogrammaticinvestments AT stoverjohn maximumcontraceptiveprevalencedemandcurveguidingdiscussionsonprogrammaticinvestments |